Ausgabe 2/2018
Inhalt (13 Artikel)
Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute
Xavier Rossello, Zhenhe He, Derek M. Yellon
Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes
Yochai Birnbaum, Mandeep Bajaj, Hsiu-Chiung Yang, Yumei Ye
Pterostilbene Decreases Cardiac Oxidative Stress and Inflammation via Activation of AMPK/Nrf2/HO-1 Pathway in Fructose-Fed Diabetic Rats
Ramoji Kosuru, Vidya Kandula, Uddipak Rai, Swati Prakash, Zhengyuan Xia, Sanjay Singh
The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway
Helison Do Carmo, Sapna Arjun, Orlando Petrucci, Derek M Yellon, Sean M Davidson
Effect of Antazoline on Electrophysiological Properties of Atrial Muscle and Conduction System of the Heart
Bartłomiej Jacek Bińkowski, Marcin Makowski, Paweł Kubiński, Andrzej Lubiński
Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials
Harold E. Bays, Robert S. Rosenson, Marie T. Baccara-Dinet, Michael J. Louie, Desmond Thompson, G. Kees Hovingh
Correction to: Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials
Harold E. Bays, Robert S. Rosenson, Marie T. Baccara-Dinet, Michael J. Louie, Desmond Thompson, G. Kees Hovingh
An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER)
Fumiki Yoshihara, Miki Imazu, Toshimitsu Hamasaki, Toshihisa Anzai, Satoshi Yasuda, Shin Ito, Haruko Yamamoto, Kazuhiko Hashimura, Yoshio Yasumura, Kiyoshi Mori, Masataka Watanabe, Masanori Asakura, Masafumi Kitakaze
Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry
Ioanna Xanthopoulou, Vasiliki-Maria Dragona, Periklis Davlouros, Costas Tsioufis, Efstathios Iliodromitis, Dimitrios Alexopoulos
Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies
Liesa K. Hoppe, Dana C. Muhlack, Wolfgang Koenig, Prudence R. Carr, Hermann Brenner, Ben Schöttker
Do the SGLT-2 Inhibitors Offer More than Hypoglycemic Activity?
Eduardo Flores, Carlos G. Santos-Gallego, Nely Diaz-Mejía, Juan Jose Badimon
Old Drugs for New Indications in Cardiovascular Medicine
Yaron Arbel, Wael Abuzeid, Robert S Rosenson, Alanna Weisman, Michael E. Farkouh
Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease
Soo-Sang Kang, Robert S. Rosenson